Bought this biotech stock in the late afternoon. Thesis was that it could squeeze shorts as the biotech sector heated up a little. It broke HOD, and when it re-broke out again I took a position right above NHOD. I was risking at 2.39, and goal was to sell at 2.90, as it had some resistance there back from July. My trade plan worked, and it was a decent trade. The pattern was good. Me following my plan was good. (Check https://www.tradervue.com/shared/users/20928 for more comprehensive analysis)